Hong Kong Consumer Durables Stock News

Sinofert Holdings (SEHK:297) has put fresh numbers on the table for FY 2025, with first half revenue of C¥14.7b and basic EPS of C¥0.16 setting the tone for how the year is shaping up. The company has seen revenue move from C¥13.7b in the first half of 2024 to C¥14.7b in the first half of 2025, while basic EPS went from C¥0.15 to C¥0.16. Trailing 12 month figures show revenue of C¥23.3b with EPS of C¥0.18, pointing to earnings that are now running ahead of headline sales. Taken together with...

First Tractor (SEHK:38) closed out FY 2025 with fourth quarter revenue of C¥1,120.1 million and a basic EPS loss of C¥0.16, while trailing twelve month EPS stood at C¥0.72 on revenue of C¥10.8 billion. Over recent quarters, revenue has ranged from C¥4,556.5 million in Q1 2025 to C¥2,371.1 million in Q2 and C¥2,774.9 million in Q3, with basic EPS moving from C¥0.47 in Q1 to C¥0.21 in Q2 and C¥0.20 in Q3 as profitability has shifted through the year. For investors, the picture is one of solid...

Shenzhen International Holdings (SEHK:152) has kicked off FY 2025 with first half revenue of HK$6.7b and basic EPS of HK$0.20, setting the tone for investors focused on how earnings quality is holding up. The company has seen revenue move from HK$6.6b in the first half of 2024 to HK$6.7b in the first half of 2025, while EPS shifted from HK$0.27 to HK$0.20 over the same periods, giving you a clear read on how the top line and per share profits are tracking year on year. Against that backdrop,...

Chaowei Power Holdings (SEHK:951) has put down a busy FY 2025 print, with first half revenue of C¥27.3b and basic EPS of C¥0.19, set against trailing twelve month revenue of C¥54.4b and EPS of C¥0.33, alongside a 24.7% earnings increase over the last year. Over recent periods the company has seen revenue move from C¥21.2b in 1H FY 2024 to C¥29.1b in 2H FY 2024 and then to C¥27.3b in 1H FY 2025, while basic EPS shifted from C¥0.18 to C¥0.08 and then C¥0.19. This frames a recovery that sits on...

Air China (SEHK:753) has followed up its full year 2025 release with a mixed final quarter, reporting Q4 revenue of CNY 41.7b alongside a basic EPS loss of CNY 0.27 per share as trailing twelve month EPS sits at a loss of CNY 0.11 on revenue of CNY 171.5b. Over recent periods, quarterly revenue has ranged from CNY 40.0b to CNY 49.1b while EPS has swung between a loss of CNY 0.27 and a profit of CNY 0.30 per share. This leaves investors weighing near term earnings volatility against the...

Home Control International (SEHK:1747) has opened FY 2025 with first half revenue of US$59.6 million and net income of US$5.0 million, translating to basic EPS of US$0.0099 and supported by trailing 12 month EPS of US$0.0139. The company has seen half yearly revenue move from US$52.1 million in 1H FY 2024 to US$55.3 million in 2H FY 2024 and then to US$59.6 million in 1H FY 2025. Over the same periods, net income shifted from US$3.2 million to a loss of US$0.7 million and then to US$5.0...

Mount Everest Gold Group (SEHK:1815) has just reported its FY 2025 numbers with first half revenue of C¥236.3 million and basic EPS of C¥0.027, set against trailing twelve month revenue of C¥487.0 million and EPS of C¥0.050 that sit alongside a 187.2% rise in net earnings over the past year. Over recent periods the company has seen revenue move from C¥220.0 million in the first half of 2023 to C¥98.5 million in the first half of 2024 and then to C¥236.3 million in the first half of 2025. EPS...

Zibuyu Group (SEHK:2420) has reported fresh numbers for FY 2025, with first half revenue of C¥1.96b and basic EPS of C¥0.22. This sets the tone for a year where trailing 12 month EPS sits at C¥0.55 on revenue of C¥4.66b. The company has seen revenue move from C¥1.46b in 1H 2024 to C¥1.86b in 2H 2024 and then to C¥1.96b in 1H 2025. Over the same periods, EPS shifted from C¥0.18 to C¥0.12 and then to C¥0.22. Together, these figures provide a clear sense of how the top and bottom lines have...

Modern Dental Group (SEHK:3600) has opened FY 2025 with first half revenue of HK$1,834.8 million and basic EPS of HK$0.30, setting a clear reference point for how its earnings story is developing. The company has seen revenue move from HK$1,701.8 million and EPS of HK$0.23 in 1H 2024 to HK$1,662.2 million and EPS of HK$0.21 in 2H 2024, before reaching HK$1,834.8 million and EPS of HK$0.30 in 1H 2025, backed by trailing 12 month earnings growth of 46.3% and a net margin that has stepped up to...

CSSC (Hong Kong) Shipping (SEHK:3877) has put fresh numbers on the table for FY 2025, with first half revenue of HK$1.7b and basic EPS of HK$0.18 setting the tone for how you assess the latest move in profitability. The company has seen revenue shift from HK$1.58b in 1H 2024 to HK$1.31b in 2H 2024 and then to HK$1.7b in 1H 2025, while basic EPS moved from HK$0.22 to HK$0.13 and then to HK$0.18 over the same stretch. This gives you a clear read on the recent earnings pattern. With net profit...

China State Construction International Holdings (SEHK:3311) FY 2025 earnings recap China State Construction International Holdings (SEHK:3311) has laid out a steady set of FY 2025 numbers, with fourth quarter revenue of about C¥24.8b and basic EPS of C¥0.37, while trailing twelve month revenue stood at roughly C¥100.4b and EPS at C¥1.64. Over recent periods, the company has seen quarterly revenue move from around HK$25.1b with basic EPS of HK$0.36 in Q4 2024 to HK$26.4b with EPS of HK$0.47 in...

Gaush Meditech (SEHK:2407) has opened FY 2025 with first half revenue of C¥653.1 million and basic EPS of C¥0.26, setting the tone for how its earnings story is evolving after a strong run in recent years. The company has seen revenue move from C¥642.0 million in 1H 2024 to C¥786.4 million in 2H 2024 and C¥653.1 million in 1H 2025, while basic EPS shifted from C¥0.19 to C¥0.43 and then to C¥0.26 over the same periods. This gives a clear view of how the top and bottom line have tracked...

Mao Geping Cosmetics (SEHK:1318) has just posted fresh FY 2025 numbers, with first half revenue of CNY 2,588.2 million and basic EPS of CNY 1.37. This is set against trailing twelve month revenue of CNY 5,050.5 million and EPS of CNY 2.46, alongside net earnings growth of 36.7% over the past year. Over recent periods, the company has seen revenue move from CNY 1,971.5 million in 1H 2024 to CNY 1,913.2 million in 2H 2024 and then to CNY 2,588.2 million in 1H 2025. Net income (excluding extra...

Ocumension Therapeutics (SEHK:1477) opened FY 2025 with first half revenue of C¥294.0 million and a basic EPS loss of C¥0.17, alongside trailing 12 month revenue of C¥804.4 million and a basic EPS loss of C¥0.20 that keeps the business in loss making territory. Over the last three reported half year periods, the company has seen revenue move from C¥167.6 million in 1H 2024 to C¥249.7 million in 2H 2024 and then to C¥294.0 million in 1H 2025. Basic EPS losses moved from C¥0.23 to C¥0.17 and...

Ju Teng International Holdings (SEHK:3336) has released its FY 2025 first half numbers, with revenue of HK$2,714.7 million and a basic EPS loss of HK$0.09, alongside net income excluding extra items of a HK$79.1 million loss. Over recent periods, the company has seen revenue move from HK$2,999.3 million in 1H 2024 to HK$3,027.0 million in 2H 2024 and HK$2,714.7 million in 1H 2025, while basic EPS shifted from a HK$0.08 loss in 1H 2024 to a HK$0.55 loss in 2H 2024 and a HK$0.09 loss in the...

Marketingforce Management (SEHK:2556) has kicked off FY 2025 with first half revenue of CN¥928.3 million and EPS of CN¥0.15, as investors weigh the latest numbers against a current share price of HK$35.48. The company has seen revenue move from CN¥739.4 million in 1H FY 2024 to CN¥819.1 million in 2H FY 2024 and CN¥928.3 million in 1H FY 2025, while EPS shifted from a loss of CN¥4.33 in 1H FY 2024 to a loss of CN¥0.24 in 2H FY 2024 before turning to a modest profit in the latest period. This...

Grand Pharmaceutical Group (SEHK:512) has opened FY 2025 with first half revenue of HK$6.1b and basic EPS of HK$0.33, setting the tone for how its earnings story is evolving after a year of shifting margins. Over recent periods the company has seen revenue move from HK$6.0b in 1H 2024 to HK$5.6b in 2H 2024 and then to HK$6.1b in 1H 2025. Basic EPS tracked HK$0.44, HK$0.26 and HK$0.33 across the same halves, giving investors a clearer view of how the top line and EPS are aligning with a...

China Resources Beverage (Holdings) (SEHK:2460) has opened FY 2025 with first half revenue of C¥6.2b and basic EPS of C¥0.34, set against a share price of HK$9.01 as investors assess how the softer headline numbers sit within the broader story. Over the same half year in 2024, revenue was C¥7.6b and basic EPS was C¥0.56. The latest release follows a period where the company had already been growing earnings at about 8.6% a year over five years, while its trailing net margin moved from 12.1%...

Everest Medicines (SEHK:1952) has reported its FY 2025 first half results with revenue of C¥446.1 million and a net loss of C¥249.8 million, translating to basic EPS of a C¥0.77 loss. The company’s revenue moved from C¥301.5 million in the first half of 2024 to C¥405.2 million in the second half of 2024, and then to C¥446.1 million in the first half of 2025. Over the same periods, net losses shifted from C¥632.4 million to C¥409.0 million and then to C¥249.8 million. Trailing twelve month...

Xtep International Holdings (SEHK:1368) has just posted its FY 2025 results with first half revenue of C¥6.8b and basic EPS of C¥0.35, set against trailing twelve month revenue of C¥14.2b and EPS of about C¥0.51 that point to steady earnings power. Over the past few first half periods, the company has seen revenue move from C¥6.5b in 2023 to C¥6.4b in 2024 and C¥6.8b in 2025, while basic EPS shifted from C¥0.26 to C¥0.34 and then to C¥0.35. This gives investors a clear sense of how...

Full year earnings set the tone for Consun Pharmaceutical Group Consun Pharmaceutical Group (SEHK:1681) released its full year 2025 results, reporting sales of CNY 3,417.36 million and net income of CNY 1,078.07 million, both higher than the prior year. Basic earnings per share from continuing operations came in at CNY 1.27, and diluted earnings per share were CNY 1.26, compared with CNY 1.11 and CNY 1.09 respectively a year earlier. See our latest analysis for Consun Pharmaceutical...

Ximei Resources Holding (SEHK:9936) has put up solid headline numbers for FY 2025, with first half revenue of C¥954.2 million and basic EPS of C¥0.26, set against trailing twelve month revenue of about C¥2.24 billion and EPS of C¥0.48 that comes with 38.2% earnings growth over the past year. The company has seen revenue move from C¥902.6 million in 1H FY 2024 to C¥919.5 million in 2H FY 2024 and then to C¥954.2 million in 1H FY 2025, while net income excluding extra items went from C¥62.3...

LVGEM (China) Real Estate Investment (SEHK:95) has released its FY 2025 first half results, reporting revenue of C¥1,039.7 million and a basic EPS loss of C¥0.31, alongside trailing 12 month revenue of C¥1,866.0 million and a basic EPS loss of C¥1.46. Over recent periods, the company has seen revenue move from C¥1,942.8 million in 1H 2024 to C¥1,771.1 million in 2H 2024 and then to C¥1,039.7 million in 1H 2025, with basic EPS losses of C¥0.30, C¥0.70 and C¥0.31 respectively. This sets up a...

Maoyan Entertainment (SEHK:1896) has reported its FY 2025 first half with revenue of C¥2.47b and basic EPS of C¥0.16, against a backdrop where trailing twelve month revenue sits at C¥4.63b and EPS at C¥0.49. Over the last three reported half year periods, revenue has moved from C¥2.17b in 1H 2024 to C¥1.91b in 2H 2024 and then to C¥2.47b in 1H 2025. Over the same periods, basic EPS has shifted from C¥0.25 to a loss of C¥0.09 and then to C¥0.16, setting a clear earnings rhythm for investors to...